Secrets, puzzles and mysteries of macroamylasemia
PDF (Русский)
DOCX (Українська)

Keywords

macroamylase, macroamylasemia, pathogenesis, diagnostics, differential diagnostics

How to Cite

Gubergrits, N. B., Byelyayeva, N. V., Lukashevich, G. M., & Mozhyna, T. L. (2020). Secrets, puzzles and mysteries of macroamylasemia. Herald of Pancreatic Club, 46(1), 12-22. https://doi.org/10.33149/vkp.2020.01.02

Abstract views: 2
PDF Downloads: 0 PDF Downloads: 1

Abstract

Physiological features of amylase synthesis and excretion are considered in the article, presence of other sources of amylase synthesis different from pancreas and salivary glands is emphasized. Definitions of hyperenzymemia and macroamylasemia (MAE) are given. MAE is a state characterized by presence of circulating complexes of normal serum amylase with protein or carbohydrates in blood. There are 3 types of MAE: first — classical (constant hyperamylasemia, decreased amylase level in urine, high blood concentration of macroamylase complexes); second — hyperamylasemia with slightly decreased amylase activity in urine, macroamylase/normal amylase ratio is less than in the first type; third — normal blood and urine amylase activity, low macroamylase/normal amylase ratio. Pathogenesis is explained by connection of blood amylase and acute phase protein in different inflammatory, infectious diseases, malabsorption. MAE clinical manifestations could be absent, sometimes abdominal pain is possible. Hyperamylasemia and reduced urine amylase activity are typical. MAE diagnostics means determination of macroamylase complexes in blood (chromatography, calculation of the clearance ratio of amylase and creatinine). The article presents clinical cases describing extra-pancreatic MAE in women with malignant ovarian lesions. The question of expediency of thorough diagnostic examination in asymptomatic MAE is raised, which may turn out to be a symptom of cancer. The lack of specific treatment for MAE is emphasized.

https://doi.org/10.33149/vkp.2020.01.02
PDF (Русский)
DOCX (Українська)

References

1. Губергриц Н. Б., Зубов, А. Д., Голубова О. А., Фоменко П. Г., Дугад Лув, Дугад Куш. Клиническое наблюдение макроамелаземии на фоне спленоза вследствие посттравматической спленэктомии (обзор литературы и клиническое наблюдение). Вестник Клуба Панкреатологов. 2014. № 1 (22). С. 50–56.
2. Губергриц Н. Б., Музыка С. В. Клиническое наблюдение эозинофильного эзофагита в сочетании с макроамилаземией. Сучасна гастроентерологія. 2018. № 5. С. 100–115.
3. Губергриц Н. Б., Лукашевич Г. М., Загоренко Ю. А. Макроамилаемия — безобидное заблуждение или опасное незнание? Сучасна гастроентерологiя. 2006. № 32 (6). С. 93–99.
4. Algin H. I., Parlar A. I., Yildiz I., Altun Z. S., Islekel G. H., Uyar I., Tulukoglu E., Karabay O. Which mechanism is effective on the hyperamylasaemia after coronary artery bypass surgery? Heart Lung Circ. 2017. Vol. 26, No 5. P. 504–508.
5. Aoki А., Hagiwara E., Atsumi Y. et al. A case report of macroamylasemia with rheumatoid arthritis. Ryumachi. 1989. Vol. 29. P. 207–212.
6. Berk J. E. Macroamylasemia. Bockus gastroenterology. 5 ed. Philadelphia, 1995. Vol. 4. P. 2851–2860.
7. Berk J. E., Kizu H., Wilding P. et al. Macroamylasemia: a newly recognized cause for elevated serum amylase activity. N. Engl. J. Med. 1967. Vol. 227. P. 941–946.
8. Burden S., Poon A. S., Masood K, Didi M. Hyperamylasaemia: pathognomonic to pancreatitis? BMJ Case Rep. 2013. pii: bcr2013009567.
9. Ceylan M. E., Evrensel A., Önen Ünsalver B. Hyperamylasemia Related to Sertraline. Korean J. Fam Med. 2016. Vol. 37, No 4. P. 259.
10. Crook M. A. Hyperamylasaemia: don’t forget undiagnosed carcinoma. Ann. Clin. Biochem. 2014. Vol. 51, No 1. P. 5–7.
11. Davis J., Berk J. E., Take S. et al. Electrophoretic characteristics of macroamylasemia serum. Clin. Chim. Acta. 1971. Vol. 35. P. 1416–1417.
12. Fridhandler L., Berk J. E. Macroamylasemia. Adv. Clin. Chem. 1978. Vol. 20. P. 267–286.
13. Galassi E., Birtolo C., Migliori M., Bastagli L., Gabusi V., Stanghellini V., De Giorgio R. A 5-year experience of benign pancreatic hyperenzymemia. Pancreas. 2014. Vol. 43, No 6. P. 874–878.
14. Gallucci F., Buono R., Ferrara L., Madrid E., Miraglia S., Uomo G. Chronic asymptomatic hyperamylasemia unrelated to pancreatic diseases. Adv. Med. Sci. 2010. Vol. 55. Р. 143e5.
15. Garcia-Gonzalez M., Defarges-Pons V., Monescillo A., Hernandez F., Cano-Ruiz A. Macrolipasemia and celiac disease. Am. J. Gastroenterol. 1995. Vol. 90, No 12. Р. 2233–2234.
16. Gonoi W., Hayashi T. Y., Hayashi N., Abe O. Association between chronic asymptomatic pancreatic hyperenzymemia and pancreatic ductal anomalies: a magnetic resonance cholangiopancreatography study. Abdom. Radiol (NY). 2019. Vol. 44, No 7. P. 2494–2500.
17. Goto H., Wakui H., Komatsuda A., Imai H., Miura А., Fujita К. Simultaneous macroamylasemia and macrolipasemia in a patient with systemic lupus erythematosus in remission. Internal Medicine. 2000. Vol. 39, No 12. Р. 1115–1118.
18. Greenberg R. E., Bank S., Singer C. Macroamylasemia in association with acquired immunodeficiency syndrome. Postgrad. Med. J. 1987. Vol. 63. P. 677–679.
19. Gullo L. Benign pancreatic hyperenzymemia. Dig. Liver Dis. 2007. Vol. 39. Р. 698e702.
20. Gullo L. Day-to-day variations of serum pancreatic enzymes in benign pancreatic hyperenzymemia. Clin. Gastroenterol. Hepatol. 2007. Vol. 5. Р. 70e4.
21. Guo S., Lv H., Yan L., Rong F. Hyperamylasemia may indicate the presence of ovarian carcinoma: a case report. Medicine (Baltimore). 2018. Vol. 97, No 49. P. e13520.
22. Guruprasad C. S., Reghu K. S., Nair M., Kumary P. K. Asymptomatic hyperamylasemia/hyperlipasemia due to pancreatic infiltration in acute lymphoblastic leukemia. Indian J. Pediatr. 2016. Vol. 83, No 1. P. 81–82.
23. Hasselbacher P., Meyers H. R., Passero F. C. Serum amylase and macroamylase in patients with systemic lupus erythematosus. Rheumatology. 1988. Vol. 27. P. 198–201.
24. Helfat A., Berk J. E., Fridhandler L. The prevalence of macroamylasemia. Further study. Am. J. Gastroenterol. 1974. Vol. 62. P. 54–58.
25. Hodgson H. J., Whitaker K. B., Cooper B. T. et al. Malabsorption and macroamylasemia. Am. J. Med. 1980. Vol. 69. P. 451–457.
26. Huang D. Y., Miao Y., Li Q. Ovarian carcinoma-associated hyperamylasemia masquerading as acute pancreatitis: a case report. Zhonghua Nei Ke Za Zhi. 2017. No 56 (10). P. 767–769.
27. Ihekweazu F. D., Nagy-Szakal D., Fishman D. S., Kellermayer R. Hyperlipasemia in pediatric inflammatory bowel diseases. Pancreas. 2016. Vol. 45, No 2. e 2–3.
28. Keating J. P., Lowe M. E. Persistent hyperlipasemia caused by macrolipase in an adolescent. J. Pediatr. 2002. Vol. 141, No 1. Р. 129–131.
29. Kimura M., Ito Y., Shimomura M., Yoneda K., Naito C., Adachi Y., Meguro T. Neutrophilia and hyperamylasemia in patients with immediate food allergy. Pediatr. Int. 2019. Vol. 61, No 1. P. 23–30.
30. Klonoff D. C. Macroamylasemia and other immunoglobulin-complexed enzyme disorders. West. J. Med. 1980. Vol. 133. P. 392–407.
31. Kobayashi K., Imagama S., Ito Z., Ando K., Shinjo R., Yagi H., Hida T., Ito K., Ishikawa Y., Ishiguro N. Hyperamylasemia and pancreatitis following posterior spinal surgery. J. Orthop. Sci. 2015. Vol. 20, No 6. P. 967–972.
32. Kohler H., Kirch W., Horstmann H. J. Hydroxyethyl starch-induced macroamylasemia. Int. J. Clin. Pharmacol. Biopharm. 1977. Vol. 15. P. 428–431.
33. Levitt M. D., Duane W. C., Cooperband S. R. Study of macroamylase complexes. J. Lab. Clin. Med. 1972. Vol. 80. P. 414–422.
34. Levitt M. D., Rappoport M., Cooperband S. R. The renal clearance of amylase in renal insufficiency, acute pancreatitis and macroamylasemia. Ann. Intern. Med. 1969. Vol. 71. P. 919–925.
35. Lionetti E., Francavilla R., Leonardi S., Tomarchio S., Gennaro A., Franzonello C., La Rosa M. Two rare cases of benign hyperlipasemia in children. World J. Clin. Cases. 2014. Vol. 2, No 1. Р. 16–19.
36. Liu S., Wang Q., Zhou R., Li C., Hu D., Xue W., Wu T., Mohan C., Peng A. Hyperamylasemia as an early predictor of mortality in patients with acute paraquat poisoning. Med. Sci. Monit. 2016. Vol. 22. P. 1342–1348.
37. Liu S.S., Chang X.H., Song J.T., Chen J., Wen J. F., Hu Y., Huang Q. Q., Guan J. M., Xu J. Risks of postendoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia after endoscopic papillary balloon dilation: a retrospective analysis. Surg. Laparosc. Endosc. Percutan. Tech. 2019. Vol. 29, No 4. P. 280–284.
38. Logie J. J., Cox M., Sharkey J. et al. A multidisciplinary approach to an unusual cause of hyperamylasaemia. BMJ Case Rep. 2015.
39. Matsuzawa K., Tsukaguchi K., Okamura H. et al. A case of lung infection due to Mycobacterium abscessus (M. abscessus) complicated with primary macroamylasemia. Nihon Kokyuki Gakkai Zasshi. 2004. Vol. 42, No 6. P. 519–522.
40. Mishler J. M., Oxon D. P., Durr G. H. K. Macroamylasemia induced by hydroxyethyl starch: confirmation by gel filtration analysis of serum and urine. Am. J. Clin. Pathol. 1980. Vol. 74. P. 387–391.
41. Nakashima Y., Funokoshi A., Kimura T. et al. A case of hyperthyroidism displaying macroamylasemia during the course of mercazol treatment. Nippon Shokakibyo Gakkai Zasshi. 1980. Vol. 77. P. 798–802.
42. Ohtani H., Sakaguchi K., Sato M. Protein contents and binding modes of immunoglobulin-amylase complexes. J. Clin. Pathol. 1982. Vol. 45. P. 385–389.
43. Oita T., Yamashiro A., Mizutani F., Tamura A., Sakizono K., Okada A. Simultaneous presence of macroamylase and macrolipase in a patient with celiac disease. Rinsho Byori. 2003. Vol. 51, No 10. Р. 974–977.
44. Okumura Y., Tamba J., Shintani Y., Yoshioka U., Inoue H., Fujiyama Y., Bamba T. Macrolipasemia in Crohn's disease. Pancreas. 1998. Vol. 16, No 2. Р. 205–220.
45. Oudart J. B., Ledon S., Poncet A., Maquart F. X., Ramont L. Hyperamylasemia after cardiac surgery: which significance? Ann. Biol. Clin. (Paris). 2011. Vol. 69, No 2. P. 223–227.
46. Sakai H., Funakoshi A., Kimura T. et al. A case of glycoprotein containing macroamylasemia associated with acute pancreatitis at early gestation. Nippon Shokakibyo Gakkai Zasshi. 1979. Vol. 76. P. 2279–2285.
47. Sanders D. S. Macroamylasemia in celiac disease: a novel observation, but what does it mean? Am. J. Gastroenterol. 2002. Vol. 97, No 4. P. 1068.
48. Schnedl W. J., Enko D., Mangge Н., Schenk М., Lackner S., Holasek S. Benign pancreatic hyperenzymemia (Gullo syndrome), histamine intolerance, and carbohydrate malabsorption. Proc. (Bayl Univ. Med. Cent.). 2017. Vol. 30, No 2. Р. 177–178.
49. Spector D., Perry Z., Shah S., Kim J. J., Tarnoff M. E., Shikora S. A. Roux-en-Y gastric bypass: hyperamylasemia is associated with small bowel obstruction. Surg. Obes. Relat. Dis. 2015. Vol. 11, No 1. P. 38–43.
50. Tsujikawa T., Bamba S., Inatomi O., Hasegawa H., Ban H., Nishida A., Imaeda H., Itoh A., Saotome T., Sasaki M., Andoh A. Factors affecting pancreatic hyperamylasemia in patients undergoing peroral single-balloon enteroscopy. Dig. Endosc. 2015. Vol. 27, No 6. P. 674–678.
51. Van Gossum A., Cremer M. Macroamylasemia disappearance after gluten withdrawal. Dig. Dis. Sci. 1989. Vol. 34. P. 964–965.
52. Vanella G., Arcidiacono P. G., Capurso G. Chronic Asymptomatic Pancreatic Hyperenzymemia (CAPH): Meta-analysis of pancreatic findings at second-level imaging. Pancreatology. 2019. Vol. 19, No 2. P. 237–244.
53. Wang H., Shao Z., Guo S. W., Jing W., Song B., Li G., He T. L., Zhou X. Y., Zhang Y. J., Zhou Y. Q., Hu X. G., Jin G. Analysis of prognostic factors for hyperamylasemia following pancreaticoduodenectomy. Zhonghua Wai Ke Za Zhi. 2019. Vol. 57, No 7. P. 534–539.
54. Wilding P., Cooke W. T., Nicholson G. I. Globulin-bound amylase. Ann. Intern. Med. 1964. Vol. 64. P. 1053–1056.
55. Yamazaki F., Terashima K., Kiyotani C., Mori T. Two cases of macroamylasemia after autologous hematopoietic stem-cell transplantation for advanced neuroblastoma. Transplantation. 2014. Vol. 98, No 1. P. e5–6.
56. Yang B. L., Wu W. C., Su C. W., Wu J. C., Yeh C., Lee S. D. Healthy Chinese with benign pancreatic hyperenzymemia. J Chin Med Assoc. 2015. Vol. 78, No 10. Р. 623–626.
57. Zackowski J. J., Bruns D. E. Biochemistry of human alfa amylase isoenzymes. Crit. Rev. Clin. Lab. Sci. 1985. Vol. 21. P. 283–322.
58. Zaman Z., Van Orshoven A., Mariën G., Fevery J., Blanckaert N. Simultaneous macroamylasemia and macrolipasemia. Clinical Chemistry. 1994. Vol. 40, No 6. P. 939–942.